about
Radiological and clinical characteristics of a military outbreak of pandemic H1N1 2009 influenza virus infection.Correlation of apparent diffusion coefficient values measured by diffusion MRI and MGMT promoter methylation semiquantitatively analyzed with MS-MLPA in patients with glioblastoma multiforme.Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.Primary diffuse leptomeningeal glioneuronal tumors.Glioblastoma treated with concurrent radiation therapy and temozolomide chemotherapy: differentiation of true progression from pseudoprogression with quantitative dynamic contrast-enhanced MR imaging.Prognosis prediction of measurable enhancing lesion after completion of standard concomitant chemoradiotherapy and adjuvant temozolomide in glioblastoma patients: application of dynamic susceptibility contrast perfusion and diffusion-weighted imaginHollow MnOxPy and Pt/MnOxPy yolk/shell nanoparticles as a T1 MRI contrast agent.Malignant glioma: MR imaging by using 5-aminolevulinic acid in an animal model.Contrast-enhanced FLAIR (fluid-attenuated inversion recovery) for evaluating mild traumatic brain injury.A case report of preoperative and postoperative 7.0T brain MRI in a patient with a small cell glioblastoma.Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.Gliomas: Histogram analysis of apparent diffusion coefficient maps with standard- or high-b-value diffusion-weighted MR imaging--correlation with tumor grade.Macrophages homing to metastatic lymph nodes can be monitored with ultrasensitive ferromagnetic iron-oxide nanocubes and a 1.5T clinical MR scanner.Glioma: application of whole-tumor texture analysis of diffusion-weighted imaging for the evaluation of tumor heterogeneity.MRI of magnetically labeled mesenchymal stem cells in hepatic failure modelNoninvasive identification of viable cell populations in docetaxel-treated breast tumors using ferritin-based magnetic resonance imaging.Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.Prognosis of Glioblastoma With Oligodendroglioma Component is Associated With the IDH1 Mutation and MGMT Methylation StatusInvestigation of inter-slice magnetization transfer effects as a new method for MTR imaging of the human brain.The Changes in MGMT Promoter Methylation Status in Initial and Recurrent GlioblastomasBody fat assessment method using CT images with separation mask algorithm.Internal mammary arteries supplying hepatocellular carcinoma: vascular anatomy at digital subtraction angiography in 97 patients.True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysisAssessment of lymph node metastases by contrast-enhanced MR imaging in a head and neck cancer modelEarly experience of pre- and post-contrast 7.0T MRI in brain tumors.Wearable/disposable sweat-based glucose monitoring device with multistage transdermal drug delivery module.Clinicopathological and genetic characteristics of extraventricular neurocytomas.Nano-sized CT contrast agents.Lymph node metastases from gastric cancer: gadofluorine M and gadopentetate dimeglumine MR imaging in a rabbit model.Magnetic resonance enhancement pattern and diagnostic accuracy of gadofluorine M in a rabbit VX2 tumor model: Comparison with gadopentetate dimeglumine.Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping.Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery.Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism.A highly facile and specific assay for cancer-causing isocitrate dehydrogenase mutant using 13C4-labeled α-ketoglutarate and heteronuclear NMR.Protective effects of cleavage agents on INS-1 cells against h-IAPP-induced apoptosis.Hepatocellular carcinoma with internal mammary artery supply: feasibility and efficacy of transarterial chemoembolization and factors affecting patient prognosis.The role of perfusion CT as a follow-up modality after transcatheter arterial chemoembolization: an experimental study in a rabbit model.Central neurocytoma: long-term outcomes of multimodal treatments and management strategies based on 30 years' experience in a single institute.
P50
Q30390953-993737F8-61A0-43C6-99AE-450B5528117DQ30571373-58AA7226-C0C7-438C-A32A-9E290FF9666FQ30649180-E8F0DE94-5708-4CCE-A8CB-D08533810A4AQ30810030-82124265-203F-4930-91DE-82E27756EF22Q30863528-0F7B37C8-34BF-405E-A732-69900DD87C2EQ30871297-7A416411-18C9-4F83-AEB2-21E8778AAE42Q30873725-1D09E819-39DC-43B8-BE6A-47A716791857Q31161256-B26951D5-03D0-4584-A673-1C5F8037F1CDQ33910779-2103FEA9-ADD8-4BF1-850F-76C768473EF3Q33913655-041536E0-E568-4DA8-8E90-9B79E681D106Q33957072-035D6214-5BB1-4BAD-ADD2-9F94CC89FFF2Q34039382-8687C45C-F6AC-4506-9C77-7F24D3AA4AD5Q34130478-7B4B5ADC-F456-4E58-BE1D-051602FDE4FEQ34277159-3AFC2F48-0A5A-42AC-B91C-F6DEC72E2E9FQ34354718-A68C64D2-5B80-41BC-9CE4-B826664FCAFFQ34542230-BBDBB11E-C480-401F-BB1F-27582638382BQ34722521-22EF5FC1-93C9-4C6F-9740-5FC50D5689EEQ34946279-A4F10AE9-F6A7-4090-BE24-C48292002894Q35028828-49E6F26A-99C9-46E2-9860-B88FA6BD4F3DQ35064286-C9DF3CBA-2CA3-4F79-B884-F3A426BF1C51Q36310665-3951E721-1171-4331-B5EF-BB6029B69A3FQ36685650-F2285E74-B916-41C0-A5B6-8A76CF8C4E12Q36710610-BF4F665F-1FA2-4D17-B1FB-0014D5CE3AA3Q37050436-BE153FCF-9056-4FEA-8C54-882E8B39A37AQ37061934-08094D88-AB3E-4037-9565-81CE4588F1CEQ37147364-C4D8D74A-0EF6-4BCC-9572-3E80B5A1DD72Q37688736-B7D960F6-596C-4D02-A2AD-1B42057E2AA9Q38016599-82BABACD-8B87-4E73-BE44-539E33B62125Q38095868-4B398D44-B224-4137-8C6C-F37D83935372Q38463361-51ABFD01-5A73-4458-96E7-6A0A1C93E8F3Q38475172-1E0FA090-4D6B-4B35-9B07-E6195F38BF99Q38475899-BD30A991-59F1-40E7-95B4-884574031162Q38490315-D426B64B-5AB2-41CC-8436-4B1EA53B8461Q38508142-A49355B7-C567-4828-8717-48696D912547Q38953709-BA594933-1333-4A48-BD48-F5235F52F091Q39058111-947AD32B-CC5C-48D7-B7E2-F992044F9AA5Q39437903-69ADFCF0-5783-41F9-8EC8-E741FB68E9B8Q39796788-76E1D75E-9103-476D-BABD-0D9590918C47Q43075227-F0F0341F-CCB0-4B26-BF59-F78D97263CA0Q43448578-84DBE7A0-889F-4F7C-A1AF-78F29AA9AE9A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Seung Hong Choi
@ast
Seung Hong Choi
@en
Seung Hong Choi
@es
Seung Hong Choi
@nl
Seung Hong Choi
@sl
type
label
Seung Hong Choi
@ast
Seung Hong Choi
@en
Seung Hong Choi
@es
Seung Hong Choi
@nl
Seung Hong Choi
@sl
prefLabel
Seung Hong Choi
@ast
Seung Hong Choi
@en
Seung Hong Choi
@es
Seung Hong Choi
@nl
Seung Hong Choi
@sl
P106
P1153
36068182300
P31
P496
0000-0002-0412-2270